These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 24524821)

  • 1. Can calcium signaling be harnessed for cancer immunotherapy?
    Rooke R
    Biochim Biophys Acta; 2014 Oct; 1843(10):2334-40. PubMed ID: 24524821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
    Amedei A; Niccolai E; Prisco D
    Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal interaction molecules as important therapeutic targets in diseases with dysregulated calcium flux.
    Mukherjee S; Brooks WH
    Biochim Biophys Acta; 2014 Oct; 1843(10):2307-14. PubMed ID: 24681268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New functions of mitochondria associated membranes in cellular signaling.
    van Vliet AR; Verfaillie T; Agostinis P
    Biochim Biophys Acta; 2014 Oct; 1843(10):2253-62. PubMed ID: 24642268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction.
    Weisthal S; Keinan N; Ben-Hail D; Arif T; Shoshan-Barmatz V
    Biochim Biophys Acta; 2014 Oct; 1843(10):2270-81. PubMed ID: 24704533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer vaccine development: on the way to break immune tolerance to malignant cells.
    Mocellin S; Rossi CR; Nitti D
    Exp Cell Res; 2004 Oct; 299(2):267-78. PubMed ID: 15350526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing immune responses to tumor-associated antigens.
    Higgins JP; Bernstein MB; Hodge JW
    Cancer Biol Ther; 2009 Aug; 8(15):1440-9. PubMed ID: 19556848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.
    Akl H; Vervloessem T; Kiviluoto S; Bittremieux M; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2240-52. PubMed ID: 24768714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
    Mapara MY; Sykes M
    J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
    Schijns V; Tartour E; Michalek J; Stathopoulos A; Dobrovolskienė NT; Strioga MM
    Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCa and Ca(2+) channels: the complex thought.
    Guéguinou M; Chantôme A; Fromont G; Bougnoux P; Vandier C; Potier-Cartereau M
    Biochim Biophys Acta; 2014 Oct; 1843(10):2322-33. PubMed ID: 24613282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of novel store-operated calcium entry effectors.
    Djillani A; Nüße O; Dellis O
    Biochim Biophys Acta; 2014 Oct; 1843(10):2341-7. PubMed ID: 24657813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dual face of connexin-based astroglial Ca(2+) communication: a key player in brain physiology and a prime target in pathology.
    De Bock M; Decrock E; Wang N; Bol M; Vinken M; Bultynck G; Leybaert L
    Biochim Biophys Acta; 2014 Oct; 1843(10):2211-32. PubMed ID: 24768716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 regulation of the inositol 1,4,5-trisphosphate receptor and calcium signaling in normal and malignant lymphocytes: potential new target for cancer treatment.
    Greenberg EF; Lavik AR; Distelhorst CW
    Biochim Biophys Acta; 2014 Oct; 1843(10):2205-10. PubMed ID: 24642270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse immunoediting: When immunity is edited by antigen.
    Merlo A; Dalla Santa S; Dolcetti R; Zanovello P; Rosato A
    Immunol Lett; 2016 Jul; 175():16-20. PubMed ID: 27131431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival.
    Ivanova H; Vervliet T; Missiaen L; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2164-83. PubMed ID: 24642269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.